Zhejiang Chinese Medical University: #298 in the world for Pharmacology, Toxicology & Pharmaceutics collaboration
Zhejiang Chinese Medical University stands at #298 of 844 universities worldwide on the Pharmacology, Toxicology & Pharmaceutics collaboration index, the strongest of its 17 subject standings in the 2026 Research Collaboration Index, published today.
The standing rests on the open scholarly record: 217 co-authored works in the field over 2021 to 2025, built with 56 collaborating institutions across 10 countries, with a field-weighted citation impact of 3.51.
Zhejiang Chinese Medical University is ranked #962 in the world.
The full index, all 26 subject rankings and complete methodology are now public.
Every figure derives from the open global research record and is checkable at source.
For universities
The GRP Partnership Intelligence Platform
Your university beside the peers you choose, across both GRP indices: the universities and companies your peers work with that you do not, live funding calls matched to your strengths, the EU projects your peers have won, and a brief ready for your executive. A partner service now onboarding founding partner universities: enquire, and the GRP team will confirm availability and pricing for your university.